API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7

CAS No.: 147526-32-7
Formula: C33h34n4o6
EINECS: 807-641-2
Environmental Protection: Yes
Certification: ISO, SGS
Color: White
Customization:
Manufacturer/Factory, Trading Company
Gold Member Since 2018

Suppliers with verified business licenses

Shaanxi, China
to see all verified strength labels (9)

Basic Info.

Classification
Cardiovascular Series
Function
Treating Cholesterol
Appearance
Powder
Price
Competitive
Delivery
Fast
Storage
Cool Dried Storage
Shelf Life
2 Years
Transport Package
Foil Bag/Drum/as Per Your Request
Specification
content ≧ 99%
Trademark
IKNOW
Origin
China

Product Description

API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7

Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins, marketed in the United States under the trade name Livalo, and in European Union and Russia under the trade name Livazo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.
 
Product Name: Pitavastatin calcium
CAS: 147526-32-7
MF: C50H46CaF2N2O8
MW: 880.98
EINECS: 807-641-2
Product Categories: Cardiovascular Series;Active Pharmaceutical Ingredients;Inhibitors;Intermediates & Fine Chemicals;-;Pharmaceuticals;chemical;API;Livalo
Molecular Structure:                              API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7

It has been available in Japan since 2003, and is being marketed in South Korea and in India.It is expected that pitavastatin will be approved outside Southeast Asia as well. In the US, it received FDA approval in 2009.Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.
 
Function
 
Like the other statins, pitavastatin is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease.
 
A 2009 study of the 104 week LIVES trial found pitavastatin increased HDL cholesterol, especially in patients with HDL lower than 40 mg/dL, who had a 24.6% rise, in addition to greatly reducing LDL cholesterol 31.3%.HDL improved in patients who switched from other statins and rose over time. In the 70-month CIRCLE observational study, pitavastatin increased HDL more than atorvastatin.
 
It has neutral or possibly beneficial effects on glucose control. As a consequence, pitavastatin is likely to be appropriate for patients with metabolic syndrome plus high LDL, low HDL and diabetes mellitus.

Application
 
Common statin-related side effects (headaches, stomach upset, abnormal liver function tests and muscle cramps) were similar to other statins. However, pitavastatin seems to lead to fewer muscle side effects than certain statins that are lipid-soluble, as a result of the fact that pitavastatin is water-soluble (as is pravastatin, for example). One study found that coenzyme Q10 was not reduced as much as with certain other statins (though this is unlikely given the inherent chemistry of the HMG-CoA reductase pathway that all statin drugs inhibit).
 
Pitavastatin appears to have improved tolerably in its metabolic profile, with a neutral effect on glucose regulation, as opposed to many statins.
 
As opposed to other statins, there is evidence that pitavastatin improves insulin resistance in humans, with insulin resistance assessed by the homeostatic model assessment (HOMA-IR) method.
 
Hyperuricemia or increased levels of serum uric acid have been reported with pitavastatin.

Packing & Shipment
 
API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7


API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7

Quality Control of Health Sources

1) A system in accordance with GMP standard, supervision on whole production process.
2) Health Sources is equipped with advanced detecting device, such as AFS, GC, HPLC, UV etc, supply the
Detailed Certificate of Analysis.

3) Procurement-Strictly on selecting raw materials.
4) Production-Strictly according to the standard specifications, conform to USP, EP, BP, CP, AJI, FCC etc
Pharmaceutical and/or food standards.

5) Warehousing and storage:Clear and dry condition with suitable temperature.
6) Transportation - Audit and supervise the logistics environment to ensure storage safety.
7) Keep samples for all batches goods to be traceable in case of quality discrepance.


API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7


Certification

API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7


API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7

API Antihypertensive Raw Material Powder Pitavastatin Calcium 147526-32-7
 
Q1:Which kind of payment terms do you accept?
For small order,you can pay by T/T or Western Union ,nomal order by T/T to our company account.

Q2:Can you give me a discount price?
Surely,It depend on your quantity.

Q3:How can I get a sample?
Free samples is available,but freight charges will be at your account and the charges will be return to you or deduct from your order in the future.

Q4:How to confirm the Product Quality before placing orders?
You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples.You can send us your product specifications and requests,we will manufacture the products according to your requests.

Q5:How do you treat quality complaint?
First of all, our quality control will reduce the quality problem to near zero.If there is a real quality problem caused by us, we will send you free goods for replacement or refund yo
u

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2018

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company
Registered Capital
3000000 RMB
Plant Area
501~1000 square meters